WASHINGTON — Patients from underrepresented groups experienced improved control of their hereditary angioedema after diagnosis, according to a presentation at the American Academy of Allergy, Asthma & Immunology Annual meeting.
However, these patients often continued to experience challenges in managing their disease, Salomé Juethner, BSN, MSN, senior medical director, Takeda Pharmaceuticals USA Inc., told Healio.
“I’ve been working in a lot of underserved types of disease areas,” Juethner told Healio.
Noting that white patients are overrepresented in clinical trials